Cargando…

High level of medication regimen complexity index correlate with worse quality of life in people living with HIV

OBJECTIVES: People living with HIV (PLWHIV) have now a near-normal life expectancy and thus, a higher risk of polypharmacy. The main objective was to assess the correlation between medication regimen complexity index (MRCI) and quality of life (EQ-5D) and health utilities among PLWHIV patients on AR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contreras-Macías, Enrique, Gutiérrez-Pizarraya, Antonio, Robustillo-Cortés, María Aguas, Morillo-Verdugo, Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2021
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019467/ https://www.ncbi.nlm.nih.gov/pubmed/33499583 http://dx.doi.org/10.37201/req/097.2020

Ejemplares similares

Beliefs and attitudes about deprescription in older HIV-infected patients: ICARD Project
por: Giménez, Reyes Serrano, et al.
Publicado: (2020)

Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study
por: Ramos, Maria Isabel Guzman, et al.
Publicado: (2021)

Determination of a cutoff value for medication regimen complexity index to predict polypharmacy in HIV+ older patient
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2019)

Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort
por: Macías, Enrique Contreras, et al.
Publicado: (2020)

Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2019)

Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019–2020
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2022)

Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
por: Cantudo-Cuenca, M. D., et al.
Publicado: (2021)

Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project
por: García-Lloret, Patricia, et al.
Publicado: (2022)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Antiviral Regimen Complexity Index as an Independent Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C
por: Galán, Rocío Jiménez, et al.
Publicado: (2013)

Effectiveness of four antiretroviral regimens for treating people living with HIV
por: Cavalcanti, Aracele Tenório de Almeida e, et al.
Publicado: (2020)

Patterns and prognosis of holding regimens for people living with HIV in Asian countries
por: Kim, Jung Ho, et al.
Publicado: (2022)

More evidence for worse COVID-19 outcomes in people with HIV
por: Boffito, Marta, et al.
Publicado: (2021)

Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2022)

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
por: Dueñas-Gutiérrez, Carlos, et al.
Publicado: (2023)

Cancer screening in people living with HIV
por: Masiá, Mar, et al.
Publicado: (2023)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Children living with HIV in Europe: do migrants have worse treatment outcomes?
por: Chappell, Elizabeth, et al.
Publicado: (2021)

An exploratory survey measuring stigma and discrimination experienced by people living with HIV/AIDS in South Africa: the People Living with HIV Stigma Index
por: dos Santos, Monika ML, et al.
Publicado: (2014)

Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens
por: Okoli, Chinyere, et al.
Publicado: (2021)

832. Body Mass Index and Quality of Life in People Living With HIV
por: Ken-Opurum, Jennifer, et al.
Publicado: (2021)

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Concurrent Use of Comedications Reduces Adherence to Antiretroviral Therapy Among HIV-Infected Patients
por: Cantudo-Cuenca, Maria Rosa, et al.
Publicado: (2014)

Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV
por: Hung, Chen-Yiu, et al.
Publicado: (2023)

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens – a discrete choice experiment
por: Aschmann, Hélène E., et al.
Publicado: (2023)

Phenotypic frailty in people living with HIV is not correlated with age or immunosenescence
por: Klotz, Stephen A., et al.
Publicado: (2022)

Greater Disability Is Associated with Worse Vestibular and Compensatory Oculomotor Functions in People Living with Multiple Sclerosis
por: Grove, Colin R., et al.
Publicado: (2022)

Implementation of a novel home delivery service during pandemic
por: Peláez Bejarano, Ana, et al.
Publicado: (2021)

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort
por: Bonfanti, Paolo, et al.
Publicado: (2020)

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort
por: Focà, Emanuele, et al.
Publicado: (2021)

Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV
por: Saborido-Alconchel, Abraham, et al.
Publicado: (2023)

Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy
por: Cingolani, Antonella, et al.
Publicado: (2022)

Measuring intersecting stigma among key populations living with HIV: implementing the people living with HIV Stigma Index 2.0
por: Friedland, Barbara A, et al.
Publicado: (2018)

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2020)

Evaluation of Patient Experience With A Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain: A Proof of Concept
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Evaluation of Patient Experience with a Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain [Response To Letter]
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs
por: Sheng, Jin, et al.
Publicado: (2016)

OUTCOMES OF PEOPLE LIVING WITH HIV IN TWO PUBLIC-SECTOR PSYCHIATRIC FACILITIES IN THE EASTERN CAPE USING EFAVIRENZ-CONTAINING REGIMENS
por: Truter, Ilse, et al.
Publicado: (2020)

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV
por: Rolle, Charlotte-Paige, et al.
Publicado: (2021)

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US
por: Pierone, Gerald, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_encb944r1b3o1dr8icumjs68ii